PTPRB and diabetic macular edema: VEPTP small molecule inhibitor AKB‐9778 was tested in clinic for diabetic macular edema and in the trial a 20% reduction in uACR was observed (Campochiaro et al., 2015; Campochiaro et al., 2016; Kevin et al., 2018).